Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum proteomic profiles suggest celecoxib-modulated targets and response predictors.

Cancer research - 15 Apr 2004

Xiao Zhen, Luke Brian T, Izmirlian Grant, Umar Asad, Lynch Patrick M, Phillips Robin K S, Patterson Sherri, Conrads Thomas P, Veenstra Timothy D, Greenwald Peter, Hawk Ernest T, Ali Iqbal U

Abstract excerpt

Cyclooxygenase-2 is a valid target for cancer prevention and treatment. This has been shown in preclinical and clinical cancer prevention studies by using a cyclooxygenase-2 inhibitor, celecoxib. When used in a randomized cancer prevention clinical trial on patients with the inherited autosomal d...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenomatous Polyposis Coli
Share to Anticarcinogenic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Blood Proteins

Share to Clinical Trials, Phase II as Topic

Share to Proteome

Share to Pyrazoles

Share to Randomized Controlled Trials as Topic

Share to Sulfonamides

Source

Identifiers

PMID: 15087410
DOI: 10.1158/0008-5472.can-03-3754

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-15087410-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Serum proteomic profiles suggest celecoxib-modulated targets and response predictors.PMID 15087410Read ↗

Integration analysis of metabolites and single nucleotide polymorphisms improves the prediction of drug response of celecoxib.Semantic proximity Read ↗

COX-2-Dependent and COX-2-Independent Mode of Action of Celecoxib in Human Liver Cancer CellsSemantic proximity Read ↗

Impact of genetic polymorphisms on adenoma recurrence and toxicity in a COX2 inhibitor (celecoxib) trial: results from a pilot study.Semantic proximity Read ↗

Combination of COX-2 expression and PIK3CA mutation as prognostic and predictive markers for celecoxib treatment in breast cancer.Semantic proximity Read ↗

Proteomic profiling of advanced hepatocellular carcinoma identifies predictive signatures of response to treatmentsSemantic proximity Read ↗

Large-scale integration of omics and electronic health records to identify potential risk protein biomarkers and therapeutic drugs for cancer preventionSemantic proximity Read ↗

A comprehensive multi-omics study reveals potential prognostic and diagnostic biomarkers for colorectal cancerSemantic proximity Read ↗

Pharmacoproteomic characterisation of human colon and rectal cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.